Navigation Links
Delcath Systems, Inc. Announces Patient Recruitment Exceeds 90%
Date:8/25/2009

NEW YORK, Aug. 25 /PRNewswire-FirstCall/ -- Delcath Systems, Inc. (Nasdaq: DCTH), a medical technology company testing its proprietary treatment method for primary and metastatic cancers to the liver, announced today that it has exceeded 90% enrollment reaching 85 patients for its pivotal Phase III Metastatic Melanoma Trial. Based on trial specifications, the Company needs 92 for enrollment achievement.

"We are pleased to report this important patient enrollment milestone. Our success validates the need for a drug delivery platform that is unique in the interventional oncology arena. With approximately 250,000 cases of primary or secondary cancer of the liver diagnosed each year in the U.S. and 2.6 million cases globally, we believe our Percutaneous Hepatic Perfusion (PHP(TM)) technology is a compelling proposition," said Eamonn Hobbs, President and CEO of Delcath Systems. "Our next milestone will be a successful review of safety data in early September in preparation for a FDA submission by mid-2010, as well as CE Mark approval, which would allow for marketing outside the U.S.A. by June 2010."

About the Phase III Study

This clinical study is testing the Delcath PHP System(TM) for the regional delivery of melphalan to the liver to treat patients with metastatic cutaneous and ocular melanoma who have unresectable tumors in the liver. The Delcath PHP System(TM) is designed to deliver significantly higher doses of anti-cancer drugs to a patient's liver while minimizing entry of the drugs into the rest of the patient's circulation. This isolation limits toxicities which result from systemic chemotherapy treatments.

Patients in the Phase III trial are randomized into one of two treatment arms, including immediate treatment with melphalan via the Del
'/>"/>

SOURCE Delcath Systems, Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. Delcath Systems Provides Update on Progress
2. Delcath Systems to Host July 27th Conference Call to Update Investors on Recent Progress
3. Delcath Systems to Host Quarterly Update Conference Call
4. Delcath Systems to Host Quarterly Update Conference Call
5. eMedical Systems, Inc. Selects MPMsoft as its Medical Billing Software Solution
6. Pitt researchers harness carbon nanomaterials for drug delivery systems, oxygen sensors
7. AdCare Health Systems, Inc. Continues To Be Profitable; Reports 2009 Second Quarter Earning Results
8. Enigma Diagnostics Announces Signing of Patent Licenses With Roche Molecular Systems, Inc.
9. OmniComm Systems, Inc. Retains Emerging Growth Equities, Ltd., as its Strategic Financial Advisor
10. Medical Data Systems, Inc. (MDS) Announces Operations Expansion and Opening of its Primary Collections Operations Office
11. Coapt Systems, Inc. Launches Hydrelle(TM) a New, FDA-Approved Dermal Filler with Lidocaine for Significant Wrinkle Correction and Greater Patient Comfort
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/28/2014)... 2014 Ticket Down is a ... in Miami, FL at the Sun Life Stadium in early ... between Argentina and Brazil has is one that has continues ... rivalries are forming on a consistent basis. The rivalry ... height in the recent 2014 World Cup. To the ...
(Date:7/28/2014)... July 28, 2014 (HealthDay News) -- British researchers report ... far fewer germs around. In their experiments, the ... more germs from one person to the other than ... the more casual exchange might suffice as a cultural ... findings are published in the August issue of the ...
(Date:7/28/2014)... is enough oxygen present to support their offspring, but ... rule. Researchers at The Johns Hopkins University have now ... enabling cancers to continue to divide even without a ... that lysosomes the cell,s protein "recycling centers" ... evidence that certain drugs can halt the growth of ...
(Date:7/28/2014)... July 28, 2014 The Oakwood Foundation ... Birkhill, Wang, Songe and Associates, PC that will benefit ... tomorrows to come. , The HBWS group is ... more than $2.5 million in donations. Through their latest ... for the Oakwood Women’s Healthcare Classic for the next ...
(Date:7/28/2014)... Salt Lake City, Utah (PRWEB) July 28, 2014 ... supplements, protein powders and drinks, announced that it will ... protein drink line of products this summer. The additional ... combined with clean pure taste-free protein , Inspire Pomegranate ... Inspire Vanilla - flavor of soft-serve vanilla cone , ...
Breaking Medicine News(10 mins):Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 2Health News:Brazil vs. Colombia Tickets in Miami: Ticket Down Slashes Colombia vs. Brazil Tickets at Sun Life Stadium in Miami for Sept. 5th Showdown 3Health News:'Fist Bump' May Beat Handshake for Cleanliness 2Health News:'Fist Bump' May Beat Handshake for Cleanliness 3Health News:Cell's recycling center implicated in division decisions 2Health News:Bariatric Eating Announces Three New Protein Shake Flavors 2
... May 8, 2012 Poor women and African Americans ... standards of care, leading to worse outcomes than among white ... presented by UC Irvine,s Dr. Robert Bristow at the Society ... women are benefiting equally from improvements in ovarian cancer care," ...
... , TUESDAY, May 8 (HealthDay News) -- Sperm cells ... tract by crawling along walls and swimming around corners, ... sperm cells are ejaculated, the few that actually reach ... new insight on how sperm travel could help scientists ...
... PHILADELPHIA - All cells have the ability to recycle unwanted ... But cancer cells have ramped up the system, called autophagy, ... of chemotherapy and other treatments. Now, researchers at the Perelman ... of Arts and Sciences, at the University of Pennsylvania, have ...
... By Maureen Salamon HealthDay Reporter , ... the counties in the United States lack a single ... graduates gravitate toward metropolitan areas, a new study indicates. ... without obstetrician-gynecologists (ob-gyns); this scarcity is more prevalent in ...
... 2012) The American Gastroenterological Association (AGA) ... (PIM) has received approval from the American ... part of ABIM,s Approved Quality Improvement (AQI) ... internal medicine subspecialists using procedural sedation can ...
... Review: Screening Women for Intimate Partner Violence May Have ... or IPV, includes a range of abusive behaviors perpetrated ... the victim. Abusive behaviors may include physical violence, sexual ... have immediate health effects on the victim. While victims ...
Cached Medicine News:Health News:UC Irvine study finds racial, economic disparities in ovarian cancer care, survival 2Health News:Sperm Collide Along Liquid Maze on Way to Fertilize Egg 2Health News:Block its recycling system, and cancer kicks the can, according to new Penn study 2Health News:Half of U.S. Counties Have No Ob-Gyn: Study 2Health News:AGA releases first independently developed ABIM-approved Practice Improvement Module in GI 2Health News:Annals of Internal Medicine tip sheet for May 8, 2012, online issue 2
(Date:7/28/2014)... 2014 Reportbuyer.com has added a new market ... 2014-2018 https://www.reportbuyer.com/product/2225723/Global-Bone-Densitometers-Market-2014-2018.html ... a special type of X-ray test used to measure ... primarily to detect osteopenia or osteoporosis, diseases in which ... fractures is high. The purpose of bone densitometry is ...
(Date:7/28/2014)... , July 28, 2014  Some 2,500 scientists and ... in Montreal for the largest ... a discipline that draws researchers from fields as far ... as diverse as designing new manufacturing processes to creating ... special time because the United Nations has declared 2014 ...
(Date:7/28/2014)... Pa. , July 28, 2014  Air Products ... uninterrupted supply of medical oxygen is vital to any ... technical innovations that not only improve the efficiency of ... Air Products will highlight these systems—including systems for ... reduce oxygen loss—from August 4-5 at the 51 ...
Breaking Medicine Technology:Global Bone Densitometers Market 2014-2018 2Global Bone Densitometers Market 2014-2018 3Global Bone Densitometers Market 2014-2018 4Global Bone Densitometers Market 2014-2018 5All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 2All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 3All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 4All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 5All About Crystals: Tiny, Giant, from Mars, from Earth's Mantle, in Medicine and in Manufacturing 6Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 2Air Products Highlights Its Medical Oxygen Supply Systems for Emergency Oxygen Supply and Reduced Oxygen Loss at ASHE 3
... Solos Endoscopy, Inc. (OTCPK: SNDY) is pleased to ... website, www.solosendoscopy.com on Friday July 1, 2011. ... existing and new customers and includes comprehensive information for ... showcases streamlined navigation to allow for easy-to-use functionality, allowing ...
... Adeona Pharmaceuticals, Inc. (NYSE Amex: AEN ), ... system diseases, announced today that it has expanded its ... Phase IIb clinical trial of patients suffering from amyotrophic ... Preparations are underway to evaluate the safety and efficacy ...
Cached Medicine Technology:Solos Endoscopy, Inc. To Launch New Corporate Website 2Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 2Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 3Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 4Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 5Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 6Adeona Executes Agreement to Initiate Phase IIb Clinical Trial of Proprietary Zinc-Based Therapy in Lou Gehrig's Disease (ALS) 7
Protective Curtain for Barriers can be used on any of our RayShield® Barriers. Whether they are ordered with the barrier or as a retrofit, RayShield Protective Curtains are easy to install with s...
Front Protection with attached Belt Guard, Built-in Back Support; Buckle Closure...
Pregnancy Apron...
All Day Comfort for the Upper Body...
Medicine Products: